Pacira BioSciences
PCRX
PCRX
130 hedge funds and large institutions have $1.69B invested in Pacira BioSciences in 2013 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 47 increasing their positions, 45 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
12% more funds holding
Funds holding: 116 → 130 (+14)
4% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 45
Holders
130
Holding in Top 10
8
Calls
$7.49M
Puts
$5.77M
Top Buyers
| 1 | +$37.8M | |
| 2 | +$28.5M | |
| 3 | +$25.5M | |
| 4 |
DCM
Daruma Capital Management
New York
|
+$20.1M |
| 5 |
CCM
Century Capital Management
Boston,
Massachusetts
|
+$19M |
Top Sellers
| 1 | -$51.4M | |
| 2 | -$49.3M | |
| 3 | -$20.7M | |
| 4 |
PWPCM
Perella Weinberg Partners Capital Management
New York
|
-$17M |
| 5 |
O
OrbiMed
New York
|
-$14.4M |